Artak Labadzhyan

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas”.

DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas

Journal of Clinical Investigation(2020)10.1172/jci138540

N/A

0DataRank · unranked

57 citations

Nan Deng, Evelyn Ding, Masaaki Yamamoto, Adam N. Mamelak, Vera Chesnokova +3 more

Endocrine Autoantibodies Determine Immune Checkpoint Inhibitor-induced Endocrinopathy: A Prospective Study

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac161

N/A

0DataRank · unranked

31 citations

Kristopher Wentzel, Omid Hamid, Kamlynn Chow, Sungjin Kim, Lawrence D. Piro +2 more

Molecular targets in acromegaly

Frontiers in Endocrinology(2022)10.3389/fendo.2022.1068061

N/A

0DataRank · unranked

11 citations

Шломо Мелмед, Artak Labadzhyan

Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?—a population-level analysis

Translational Andrology and Urology(2023)10.21037/tau-23-114

N/A

0DataRank · unranked

2 citations

Nadine A. Friedrich, Lauren E. Howard, Taofik Oyekunle, Amanda M. De Hoedt, Artak Labadzhyan +4 more